SHL Telemedicine Ltd. (SWX: SHLTN)

Market Cap	40.65M
Revenue (ttm)	50.27M
Net Income (ttm)	-7.94M
Shares Out	16.39M
EPS (ttm)	-0.57
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,293
Open	2.500
Previous Close	2.500
Day's Range	2.400 - 2.500
52-Week Range	2.220 - 8.200
Beta	0.38
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 27, 2024

About SHL Telemedicine

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen’C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio’B, a portable device to transmit a 12-lead ECG. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monito...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1986
• Employees: 583
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: SHLTN

Financial Performance

In 2023, SHL Telemedicine's revenue was $57.08 million, a decrease of -3.26% compared to the previous year's $59.00 million. Losses were -$7.06 million, 9184.2% more than in 2022.

Financial numbers in USD